The review research on “Epidermal Growth Factor Receptor (EGFR) in Glioblastoma” by Xu et al. [104] focuses on various aspects such as EGFR mutation in glioblastoma, EGFR therapies in glioblastoma, and glioblastoma’s dysregulated EGFR signaling networks such as PI3K, MAPK. Here, EGFR is linked to glioblastoma.